A medical technology company that employs 500 people here should get a significant boost – translating into more jobs – from President Obama’s economic stimulus package, Gov. Deval Patrick said Thursday.
Patrick’s remarks came during a tour of eClinicalWorks’ Rte. 9 headquarters where he and officials were shown the software that allows physicians and other health care workers to tap into up-to-the-minute information on patients.
“The very good Read the rest of this entry »

The FDA did not formally announce the new findings about the company’s testing, but rather made small revisions to an online report about the investigation on Thursday. Only when a Washington Post reporter discovered the changes did the news become more widely known.
As part of the investigation, the FDA found that 12 contaminated lots from the small Blakely, Ga., plant were shipped to schools in California, Minnesota and Iowa from January 2007 Read the rest of this entry »

Tuesday, February 03, 2009
WASHINGTON —  The Associated Press has learned a processing plant in Texas run by the same company blamed for a national salmonella outbreak operated uninspected and unlicensed for years.
Texas health records show the Peanut Corporation of America plant in Plainview had never been inspected until after the company recently fell under investigation by the U.S. Food and Drug Administration.
FDA inspectors went Read the rest of this entry »

DALLAS
— A health care company hired to manage a program for elderly Texans as part of a broad privatization plan was fined more than $1 million by the state in the past year over mounting complaints that included delayed or denied medical care.
Evercare of Texas, a unit of Minnesota-based UnitedHealth Group, has drawn the ire of some powerful Austin lawmakers over its management of preventative and long-term care for the state’s most Read the rest of this entry »

LYNCHBURG, Va. – The family in charge of the company that shipped salmonella-contaminated peanut products blamed for sickening hundreds of people claims that reports of filthy condition at the company’s shuttered Georgia plant are “exaggerated” and insists that the company broke no laws.
The Food and Drug Administration alleges that Peanut Corp. of America knowingly distributed peanut products from its plant in Blakely, Ga., that had tested Read the rest of this entry »

RESEARCH TRIANGLE PARK, N.C.
— Amidst all the frantic news about Steve Jobs and his medical leave of absence from Apple, one thought should remain paramount: Prayers for him and his family.
While Wall Street focuses on the billions of dollars of shareholder value that Apple lost Wednesday when Jobs disclosed his decision and on what his departure means for the company, let’s not forget Jobs is a human being with a family.
That said, Read the rest of this entry »

A medical technology company that employs 500 people here should get a significant boost – translating into more jobs – from President Obama’s economic stimulus package, Gov. Deval Patrick said yesterday.
Patrick’s remarks came during a tour of eClinicalWorks’ Rte. 9 headquarters where he and officials were shown the software that allows physicians and other health care workers to tap into up-to-the-minute information on patients.
“The very good Read the rest of this entry »

(NaturalNews) The FDA has approved 18 products for market from generic drug manufacturer Ranbaxy Laboratories, even though the company is currently being investigated by Congress for making substandard products and conspiring to fraudulently cover it up.
“Allegations from reliable sources and supporting documents indicate a pattern of systemic fraudulent conduct, including submissions by Ranbaxy to the FDA that contain false and fabricated information,” Read the rest of this entry »

In addition to historical information this press release may contain
“forward-looking statements” that are made in good faith by EIHI pursuant to
the “safe harbor” provisions of the private Securities Litigation Reform Act
of 1995. These forward-looking statements include statements with respect to
strategies, goals, beliefs, expectations, intentions, results of operations,
future performance and business of EIHI. Numerous competitive, economic,
regulatory, Read the rest of this entry »

For years, pharmaceutical companies have asked Congress to pass a law protecting them from liability lawsuits for drugs that have been approved by the U.S. Food and Drug Administration. Members of Congress, knowing only too well the fallibility of the FDA in approving drugs and monitoring their safety after approval, have rightly refused.
Now one drug company is trying to get the Supreme Court to rule that an FDA-approved warning label on its drug Read the rest of this entry »